Dr. William Allen Gilmore II, MD

Dr. Gilmore practices at Diagnostic Pathology Associates in Beaumont, Texas.

Dr. Gilmore's NPI, 1831197136, was assigned on July 11, 2005. Dr. Gilmore graduated from UTMB Health in 1979. Dr. Gilmore holds Texas license F3998.

Dr. Gilmore's primary practice is Diagnostic Pathology Associates, at 3530 Fannin, Beaumont, TX 77701. The practice phone is (409) 842-8222.

Dr. Gilmore's primary practice is Diagnostic Pathology Associates in Beaumont, Texas. Dmand AI also links Dr. Gilmore to 1 physician office, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Gilmore practices, 2 sites in all. Vendor and product names are available with a free account.

Dermatology is Dr. Gilmore's primary specialty in the NPI Registry, under taxonomy code 207N00000X. Dr. Gilmore is board certified in dermatology by the American Board of Dermatology. Dmand AI has Dr. Gilmore's licenses on file in 2 states: Texas and Oklahoma.

Dmand AI lists acne, acute skin infection, benign or precancerous skin growths, cancerous skin growth removal, cold sores or genital herpes, contact dermatitis, hives and itchy rashes among the conditions Dr. Gilmore treats.

CMS data shows 6,827 Medicare services from Dr. Gilmore across 27 procedure codes in 2024, for 712 Medicare patients. Medicare paid $198,547 for them. Every service was in an office.

CMS counts 712 Medicare patients who saw Dr. Gilmore in 2024. The largest group is 75 to 84, with 294 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.12, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Gilmore's median patient age at 74, with 50% women.

In 2024, Dr. Gilmore wrote 866 Medicare Part D claims for 326 patients. 97% of them were for generic drugs. CMS names the drug for 693 of them, across 13 drugs with 11 or more claims each, at $18,049 in total drug cost. In 2023, CMS named 608 claims across 11 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Gilmore for performance year 2024, reported individually. Dr. Gilmore accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 1,116 procedures of removal of skin lesions by Dr. Gilmore, more than 94% of the clinicians it reports for that procedure.

Melanoma (skin cancer) excision: 1 to 10 procedures (CMS shows small counts as a range)

Skin biopsy: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 2 papers to Dr. Gilmore. The most frequent topics are Skin Diseases, Bacterial and Skin Neoplasms. Dr. Gilmore has published most often in Am J Dermatopathol. Dr. Gilmore's most frequent co-authors are Christina Raines Hopkins and Vicky Ren, MD.

CMS Open Payments shows 103 general payments to Dr. Gilmore from 20 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 98% of the total. Janssen Pharmaceuticals, Inc paid the most, $2,446.

Dmand AI lists 1 award for Dr. Gilmore.

Dr. Gilmore graduated from UTMB Health in 1979. Dr. Gilmore is a member of AAD.

Dr. Gilmore is in network with 14 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 9. Check the plan with the practice before a visit.